Loading...
Anti-MPL Recombinant Antibody Products
Loading...Anti-MPL Products
- Anti-Human MPL Recombinant Antibody (VB22B) (TAB-157CQ)
-
- Species Reactivity: Human, Cynomolgus monkey
- Application: ELISA, FC
- Rabbit Anti-MPL Recombinant Antibody (clone R03-1C9) (VS3-FY1910)
-
- Species Reactivity: Human, Mouse, Rat
- Type: Rabbit IgG
- Application: WB
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, ELISA, FC, ICC, IF, IHC
- Anti-Human MPL Recombinant Antibody (TAB-534CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Antibody
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Human Anti-MPL Recombinant Antibody (TAB-155CQ) (TAB-155CQ)
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: ELISA, FC, FuncS
- Human Anti-MPL Antibody, mRNA (TAB-534CL-mRNA)
-
- Species Reactivity: Human
- Mouse Anti-MPL Recombinant Antibody (clone 1H2) (VS3-XY1093)
-
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: ELISA, WB, FC
- Mouse Anti-MPL Recombinant Antibody (clone 1D6B7) (VS3-XY1094)
-
- Type: Mouse IgG2a
- Rat Anti-Mouse Mpl Recombinant Antibody (clone AMM2) (VS-0224-XY88)
-
- Species Reactivity: Mouse
- Type: Rat IgG1
- Application: WB, FC, IP, Neut
- Rabbit Anti-MPL Recombinant Antibody (VS-0224-XY94) (VS-0224-XY94)
-
- Species Reactivity: Human, Mouse
- Type: Rabbit IgG
- Application: WB, IP, IHC
- Human Anti-MPL Recombinant Antibody (clone 5E5) (HPAB-S0097-YC)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, Agonist
- Human Anti-MPL Recombinant Antibody (clone 10D10) (HPAB-S0096-YC)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, Agonist
- Human Anti-MPL Recombinant Antibody (clone 10F6) (HPAB-S0095-YC)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, Agonist
- Mouse Anti-MPL Recombinant Antibody (HPAB-1580-FY) (HPAB-1580-FY)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, FC, ELISA
- Mouse Anti-MPL Recombinant Antibody (HPAB-1581-FY) (HPAB-1581-FY)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FC
- Mouse Anti-MPL Recombinant Antibody (HPAB-1582-FY) (HPAB-1582-FY)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA
- Mouse Anti-MPL Recombinant Antibody (HPAB-0411-YC) (HPAB-0411-YC)
-
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: FC, ELISA
- Human Anti-MPL Recombinant Antibody (HPAB-0412-YC) (HPAB-0412-YC)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: FC, FuncS
- Mouse Anti-MPL Recombinant Antibody (HPAB-0568-CN) (HPAB-0568-CN)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: ELISA, FC, Block
-
- Species Reactivity: Human
- Type: Human antibody
- Application: FC, FunS, ELISA
-
- Species Reactivity: Human
- Type: Human antibody
- Application: FC, FunS, ELISA
-
- Species Reactivity: Human
- Type: Human antibody
- Application: FC, FunS, ELISA
- Mouse Anti-MPL Recombinant Antibody (HPAB-0566-CN) (HPAB-0566-CN)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG2b, κ
- Application: ELISA, FC, Block
- Mouse Anti-MPL Recombinant Antibody (HPAB-0567-CN) (HPAB-0567-CN)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG2b, κ
- Application: ELISA, FC, Block
- Human Anti-MPL Recombinant Antibody; scFv Fragment (TAB-155CQ-S(P)) (TAB-155CQ-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, FC, WB
- Human Anti-MPL Recombinant Antibody; Fab Fragment (TAB-155CQ-F(E)) (TAB-155CQ-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, FC, WB
- Anti-Human MPL Recombinant Antibody Fab Fragment (TA136) (TAB-156CQ-F(E))
-
- Species Reactivity: Human
- Application: ELISA, FC
- Anti-Human MPL Recombinant Antibody Fab Fragment (VB22B) (TAB-157CQ-F(E))
-
- Species Reactivity: Human, Cynomolgus monkey
- Application: ELISA, FC
- Human Anti-MPL Recombinant Antibody (clone 5E5); scFv Fragment (HPAB-S0097-YC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, Agonist
- Anti-Human MPL Recombinant Antibody scFv Fragment (TA136) (TAB-156CQ-S(P))
-
- Species Reactivity: Human
- Application: ELISA, FC
- Anti-Human MPL Recombinant Antibody scFv Fragment (VB22B) (TAB-157CQ-S(P))
-
- Species Reactivity: Human, Cynomolgus monkey
- Application: ELISA, FC
- Mouse Anti-MPL Recombinant Antibody; scFv Fragment (HPAB-0566-CN-S(P)) (HPAB-0566-CN-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC, Block
- Mouse Anti-MPL Recombinant Antibody; scFv Fragment (HPAB-0567-CN-S(P)) (HPAB-0567-CN-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC, Block
- Mouse Anti-MPL Recombinant Antibody; scFv Fragment (HPAB-0568-CN-S(P)) (HPAB-0568-CN-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC, Block
- Mouse Anti-MPL Recombinant Antibody; Fab Fragment (HPAB-0566-CN-F(E)) (HPAB-0566-CN-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, FC, Block
- Mouse Anti-MPL Recombinant Antibody; Fab Fragment (HPAB-0567-CN-F(E)) (HPAB-0567-CN-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, FC, Block
- Mouse Anti-MPL Recombinant Antibody; scFv Fragment (HPAB-0411-YC-S(P)) (HPAB-0411-YC-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC, ELISA
- Human Anti-MPL Recombinant Antibody scFv Fragment (HPAB-0412-YC-S(P)) (HPAB-0412-YC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: FC, FuncS
- Mouse Anti-MPL Recombinant Antibody; Fab Fragment (HPAB-0411-YC-F(E)) (HPAB-0411-YC-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: FC, ELISA
- Mouse Anti-MPL Recombinant Antibody; Fab Fragment (HPAB-1580-FY-F(E)) (HPAB-1580-FY-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA
- Mouse Anti-MPL Recombinant Antibody; Fab Fragment (HPAB-1581-FY-F(E)) (HPAB-1581-FY-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA
- Mouse Anti-MPL Recombinant Antibody; Fab Fragment (HPAB-0568-CN-F(E)) (HPAB-0568-CN-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, FC, Block
- Human Anti-MPL Recombinant Antibody (clone 10F6); Fab Fragment (HPAB-S0095-YC-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, Agonist
- Human Anti-MPL Recombinant Antibody Fab Fragment (HPAB-0412-YC-F(E)) (HPAB-0412-YC-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: FC, FuncS
- Human Anti-MPL Recombinant Antibody (clone 10D10); Fab Fragment (HPAB-S0096-YC-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, Agonist
- Human Anti-MPL Recombinant Antibody (clone 10D10); scFv Fragment (HPAB-S0096-YC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, Agonist
- Human Anti-MPL Recombinant Antibody (clone 5E5); Fab Fragment (HPAB-S0097-YC-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, Agonist
- Mouse Anti-MPL Recombinant Antibody; Fab Fragment (HPAB-1582-FY-F(E)) (HPAB-1582-FY-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA
- Mouse Anti-MPL Recombinant Antibody; scFv Fragment (HPAB-1580-FY-S(P)) (HPAB-1580-FY-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA
- Mouse Anti-MPL Recombinant Antibody; scFv Fragment (HPAB-1581-FY-S(P)) (HPAB-1581-FY-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA
- Mouse Anti-MPL Recombinant Antibody; scFv Fragment (HPAB-1582-FY-S(P)) (HPAB-1582-FY-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA
- Human Anti-MPL Recombinant Antibody (clone 10F6); scFv Fragment (HPAB-S0095-YC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, Agonist
- Anti-Human MPL Recombinant Antibody (TA136) (TAB-156CQ)
-
- Species Reactivity: Human
- Application: ELISA, FC
- Human Anti-MPL (clone 5E5) scFv-Fc Chimera (VS-0325-FY143)
-
- Species Reactivity: Human
- Type: Human IgG1, scFv-Fc
- Application: ELISA
-
- Species Reactivity: Human
- Target: MPL
- Host Animal: Mouse
- Application: Block, ELISA, FC, Cell-uptake
-
- Species Reactivity: Human
- Target: MPL
- Type: Tandem scFv
- Application: Block, ELISA, FC
-
- Derivation: Phage display library screening
- Species Reactivity: Human
- Type: IgG
- Application: FC, WB
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs is at the forefront of providing premium anti-MPL recombinant antibody products, expertly developed to support the intricate research and therapeutic development efforts of our global clientele. These highly specific and potent antibodies are instrumental in driving scientific advancements, enabling researchers to uncover critical insights into MPL's role in immune regulation and various disease pathologies.
MPL: A Pivotal Target for Hematological Disorders and Therapies
The myeloproliferative leukemia protein (MPL) is the receptor for thrombopoietin (TPO), a critical cytokine governing megakaryocyte differentiation and platelet production. Extensive research has unveiled its crucial role in hematopoietic stem cell maintenance and its dysregulation in various hematological disorders. A deeper understanding of MPL signaling is paramount for developing targeted and more efficacious therapies for conditions such as myeloproliferative neoplasms and thrombocytopenias.
Alternative Names
MPL proto-oncogene; thrombopoietin receptor; MPLV; TPOR; C-MPL; CD110; THPOR; THCYT2; TPO receptor.
Background
In 1990 an oncogene, v-mpl, was identified from the murine myeloproliferative leukemia virus that was capable of immortalizing bone marrow hematopoietic cells from different lineages. In 1992 the human homologue, named, c-mpl, was cloned. Sequence data revealed that c-mpl encoded a protein that was homologous with members of the hematopoietic receptor superfamily. Presence of anti-sense oligodeoxynucleotides of c-mpl inhibited megakaryocyte colony formation. The ligand for c-mpl, thrombopoietin, was cloned in 1994. Thrombopoietin was shown to be the major regulator of megakaryocytopoiesis and platelet formation. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs. TPO-R deficient mice were severely thrombocytopenic, emphasizing the important role of CD110 and thrombopoietin in megakaryocyte and platelet formation. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.
Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes
Intracellular, Membrane (different isoforms)
Group enriched (Erythroid cells, Excitatory neurons, Oligodendrocytes)
Immune cell enhanced (neutrophil)
Cell line enriched (HEL)
Homodimer (PubMed:25538044). Interacts with ATXN2L.
Receptor
Anti-MPL rAb Products
Creative Biolabs proudly presents a diverse array of anti-MPL recombinant antibody products, engineered to deliver exceptional specificity and high binding affinity. Our commitment to advanced recombinant technology ensures unparalleled consistency and purity, which are vital for achieving dependable and repeatable outcomes in demanding research applications. These advanced tools are indispensable for precise target validation, effective drug screening, and robust diagnostic assay development.
Table 1. Featured anti-MPL recombinant antibody products at Creative Biolabs.
| Cat. No. | Product Name | Target Species | Host Species | Applications |
| TAB-157CQ | Anti-Human MPL Recombinant Antibody (VB22B) | Human, Cynomolgus monkey | Mouse | ELISA, FC |
| VS3-FY1910 | Rabbit Anti-MPL Recombinant Antibody (clone R03-1C9) | Human, Mouse, Rat | Rabbit IgG | WB |
| HPAB-1580-FY | Mouse Anti-MPL Recombinant Antibody (HPAB-1580-FY) | Human | Mouse IgG | WB, FC, ELISA |
| HPAB-1581-FY | Mouse Anti-MPL Recombinant Antibody (HPAB-1581-FY) | Human | Mouse IgG | FC |
| HPAB-0411-YC | Mouse Anti-MPL Recombinant Antibody (HPAB-0411-YC) | Human | Mouse IgG1, κ | FC, ELISA |
Creative Quality Control
At Creative Biolabs, our anti-MPL recombinant antibody products undergo rigorous, multi-stage quality control to guarantee their exceptional performance. Utilizing advanced techniques like ELISA, Western Blot, and flow cytometry, we verify antibody specificity, binding affinity, and functionality. This comprehensive quality assurance approach guarantees that our clients always receive the finest quality antibodies, allowing them to generate trustworthy and effective experimental findings.
Fig.1 WB analysis of anti-MPL antibody
(Cat# VS3-FY1910, Creative Biolabs).
Customer Reviews
Anti-Human MPL Recombinant Antibody (TAB-534CL)
Rabbit Anti-MPL Recombinant Antibody (clone R03-1C9) (VS3-FY1910)
Human Anti-MPL Recombinant Antibody (TAB-155CQ) (TAB-155CQ)
rAb Production
Our anti-MPL recombinant antibodies are produced using state-of-the-art expression systems and proprietary purification technologies. This advanced manufacturing process ensures high yields of highly purified, functional antibodies, free from common contaminants. Our commitment to cutting-edge production methodologies guarantees products that meet the most demanding research and development specifications.
Featured Anti-MPL Recombinant Antibody Production Platforms
Fig.2 Milligram-scale anti-MPL recombinant antibody production.
Fig.3 Gram-scale anti-MPL recombinant antibody production.
rAb Modalities
Creative Biolabs' anti-MPL recombinant antibody products are available in multiple modalities, offering versatility for a wide array of research applications.
Fig.4 Full-length anti-MPL recombinant antibody production and modalities.
MPL-Targeted Drug Information
Table 2. Public drug targeting MPL.
| Company | Research phase | Classification | Condition |
|
Amgen (Originator) Kyowa Hakko Kirin (Kyowa Kirin) Kyowa Kirin |
Launched - 2008 |
Fc Fusion Proteins Polypeptides, from 41 AA |
Acute radiation syndrome Aplastic anemia Myelotoxicity Radiation injury Thrombocythemia Thrombocytopenia Thrombocytopenia, immune (Purpura, idiopathic thrombocytopenic) |
| 3SBio (Originator) | Launched |
Polypeptides, from 41 AA Recombinant proteins |
Thrombocytopenia Thrombocytopenia, immune (Purpura, idiopathic thrombocytopenic) |
|
Bristol-Myers Squibb (Originator) Genentech (Originator) Kirin Holdings Pfizer |
Phase II |
Megakaryocyte Colony-Stimulating Factor (Meg-CSF) Polypeptides, from 41 AA Recombinant proteins |
Anemia Neutropenia Thrombocythemia |
| Allogene Therapeutics (Originator) | Phase I/II |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) (Second-Generation CAR) Chimeric Cytokine Receptor-Modified T Cells (CCR T Cells) |
Multiple myeloma |
| Clover Biopharmaceuticals (Originator) | Phase I |
Fc Fusion Proteins Polypeptides, from 41 AA |
Cytopenia, chemotherapy- or radiotherapy-induced |
|
Daegu Gyeongbuk Institute Sci Technol (Originator) Inje University (Originator) Kosin University (Originator) |
Preclinical |
Agonist Antibodies Fc Fusion Proteins Polypeptides, from 41 AA Single-Chain V-Domain Antibody Fragment (scFv) |
Thrombocytopenia |
| Allogene Therapeutics (Originator) | Preclinical |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) (Second-Generation CAR) Chimeric Cytokine Receptor-Modified T Cells (CCR T Cells) |
Cancer |
| Allogene Therapeutics (Originator) | Preclinical |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) (Second-Generation CAR) Chimeric Cytokine Receptor-Modified T Cells (CCR T Cells) |
Cancer |
| Emory University (Originator) | Preclinical |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) (First-Generation CAR) |
Acute myeloid leukemia |
| Alexion Pharmaceuticals (Originator) | Preclinical | Agonist Antibodies | Thrombocytopenia |
| Chugai Pharmaceutical (Originator) | Preclinical | Monoclonal Antibodies | Thrombocytopenia |
(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)
Creative Biolabs is dedicated to supporting your scientific endeavors with our premium anti-MPL recombinant antibody products. Please contact us immediately if you would like to learn more or discuss your unique project requirements. Our skilled staff is ready to give customized solutions and thorough assistance for your research requirements.

